CAS-One IR CIRSE Lisbon Recap

2024 is a milestone year for CAS-One IR in numbers. In a few months we will exceed 75 hospitals using the system, and 10,000 patients treated- but one small metric has already been achieved: having two systems on the booth instead of one for the first time ever. This was very much needed as our team was giving demonstrations of the new software (v4.2) constantly to both existing Quality Ablation users, as well as completely new physicians.

The scientific agenda had multiple CAS-One IR appearances. Dr. Bruno Odisio, from MD Anderson (USA) spoke on Predictive Software for Percutaneous Ablation and spoke a bit about his CAS-One IR use. Iwan Paolucci, also in the group at MD Anderson was first author on a poster outlining their experience with ~100 patients (so far) treated in their institution. Finally, in a highly attended SPHAIRE session (standing room only in the back) our very own Benjamin Eigl outlined how the AI that drives CAS-One IR works in the present, and how it could work in the future to further advance percutaneous tumor treatments. There were also interesting cases accepted as posters from CAS-One IR users from Freiburg (DE) and Regensburg (DE)

All of these sessions can be viewed here:

Predictive Software for Percutaneous Ablation - B. Odisio

Initial experience from stereotactic thermal ablation for liver tumors in a large academic center in the United States - I. Paolucci

Microwave ablation of a HCC in a challenging location adjacent to the portal vein and inferior vena cava - V. Mayr

Stereotactic navigated electrochemotherapy for a treatment of a non-resectable/non-thermal treatable liver metastasis M. Doppler 

Leading the future of interventional oncology: innovations in stereotactic ct-guided tumor ablation B.Eigl

Our second iteration of the CAS-One IR AI Challenge was introduced. This was a two part challenge - first, assessing an ablation zone (% of tumor, and margin) with the "eyeballing" approach, compared to what AI driven AblaSure indicates, and second, choosing the reablation target based on that final scan. Congratulations to Laurynas Kazlas from Aarhus University Hospital (DK) for winning and Gáspár Tamás | University of Pécs.

The Hands-on session was an opportunity to spend a bit more of dedicated time with participants who had a special interest in planning, navigation, and ablation confirmation. Our team took 1-hour to walk through CAS-One IR with these participants. Thanks very much to Prof. Reto Bale for hosting this session.

Monday evening, we hosted a side event with over 100 attendees. Levent Kara (Zurich, CH) spoke about his extensive experience and results (including 3 year follow-ups) with Kidney Ablation using CAS-One IR.  Prof. Julien Frandon (Nîmes, FR) spoke about Margin Confirmation in the Liver, and very specifically how CAS-One IR has helped him see what "eyeballing" might have missed!

After the presentations, there were discussions over dinner and the evening was capped-off by our very own "DJ Quality Ablation".

We look forward to CIRSE raising the bar even more next year in Barcelona!